Global Facial Injectables Market 2017-2025 - $15 Bn Growth Trends, Key Players, Competitive Strategies

Global Facial Injectables Market 2017-2025 - $15 Bn Growth Trends, Key Players, Competitive Strategies

PR Newswire

DUBLIN, September 12, 2017

DUBLIN, September 12, 2017 /PRNewswire/ --

The "Global Facial Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The market was valued at USD 5.1 Bn in 2015, and is expected to reach USD 15.1 Bn by 2025, expanding at a CAGR of 12.4% from 2017 to 2025.

Facial injectables or fillers are used in aesthetic medical procedures to enhance the facial look. Facial injectables are used with an intent to smoothen the wrinkles or scars on the face by filling or puffing up the target area. The major kinds of facial injectables used are botulinum toxin, hyaluronic acid, collagen, polymers and particles. The polymers and particles are further segmented into polymethylmethacrylate beads (PMMA microspheres), Poly-L-lactic acid, and calcium hydroxyapatite. Hyaluronic acid held the largest share in the global facial injectables market due to increased usage of this products as dermal fillers in aesthetic surgeries.

Moreover, hyaluronic acid has major benefits as it increases hydration, improves elasticity and reverses free radical damage that protects from UV damage. These factors would continue to drive the market for hyaluronic acid with a healthy growth rate. Polymers and particles, are anticipated to be the fastest growing product segment by the end of the forecast period owing to having less side effects than other facial injectable products and higher longevity of the effect.

In base year 2015, North America was the most dominating regional market for facial injectables, with U.S. holding the largest market share in North America due to higher awareness about aesthetic surgical procedures in the region. Factors such organized regulatory framework and reimbursement scenarios are further assisting the facial injectables market in North America. According to International Society of Aesthetic Plastic Surgery (ISAPS), U.S. holds the largest number of facial filling procedures carried out all over the world. Asia-Pacific is anticipated as the most attractive market with highest growth rate during the forecast period. Rising disposable income, developing awareness regarding aesthetic and plastic surgeries in the regions, especially in the countries such as India, South Korea and China are driving the facial injectables market in Asia-Pacific. Moreover, rapidly developing healthcare infrastructure, medical tourism and booming entertainment industry would further boost the growth of facial injectables market in Asia-Pacific.

The companies include, Merz Pharma GmbH & Co. KGaA, Bloomage BioTechnology Corporation Limited, Allergan, Inc., Galderma S.A., and Ipsen Group and Others.

Key Market Movements:

Key Topics Covered:

Chapter 1 Preface
1.1 Report Description
1.2 Research Scope
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Facial Injectables Market Portraiture
2.2 Facial Injectables Market, by Product, 2016 (US$ Mn)
2.3 Facial Injectables Market, by Geography, 2016 (Value %)

Chapter 3 Global Facial Injectables Market Analysis
3.1 Global Facial Injectables Market Overview
3.2 Market Dynamics
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Facial Injectables Market, 2016 (Value %)

Chapter 4 Global Facial Injectables Market, by Product
4.1 Overview
4.2 Botulinum Toxin
4.3 Hyaluronic Acid
4.4 Collagen
4.5 Polymers and Particles (Ppfs)
4.5.1 Polymethylmethacrylate Beads (Pmma Microspheres)
4.5.2 Poly-L-Lactic Acid
4.5.3 Calcium Hydroxyapatite

Chapter 5 Global Facial Injectables Market, by Geography

Chapter 6 Company Profiles
6.1 Advanced Dermatology
6.2 Merz, Inc
6.3 Bloomage Biotechnology Corporation Limited
6.4 Galderma Laboratories, L.P
6.5 Colbar Lifescience Ltd
6.6 Allergan, Plc
6.7 Ipsen Group
6.8 Valeant Pharmaceuticals
6.9 Sanofi Biosurgery Inc
6.10 Anika Therapeutics, Inc

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Voltar noticias em Inglês